Two Sigma Securities LLC Takes Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Two Sigma Securities LLC acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 23,688 shares of the company's stock, valued at approximately $463,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in PRVA. First Horizon Advisors Inc. boosted its stake in Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after acquiring an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock worth $47,000 after acquiring an additional 2,350 shares during the period. Financial Management Professionals Inc. purchased a new stake in Privia Health Group in the 4th quarter worth about $51,000. Quadrant Capital Group LLC lifted its holdings in Privia Health Group by 11.8% during the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock valued at $95,000 after purchasing an additional 511 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of Privia Health Group by 185.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock worth $98,000 after purchasing an additional 3,249 shares in the last quarter. Institutional investors own 94.48% of the company's stock.

Privia Health Group Stock Down 2.5 %

Shares of NASDAQ PRVA traded down $0.58 during midday trading on Thursday, hitting $22.90. The stock had a trading volume of 732,128 shares, compared to its average volume of 772,607. The company has a market cap of $2.78 billion, a P/E ratio of 229.02, a PEG ratio of 3.47 and a beta of 0.88. The business's 50 day moving average is $23.55 and its 200-day moving average is $22.00. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04.

Insider Buying and Selling at Privia Health Group

In related news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88. This trade represents a 3.04 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 10.70% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PRVA. Needham & Company LLC reissued a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. JMP Securities restated a "market outperform" rating and issued a $29.00 price objective on shares of Privia Health Group in a research report on Monday. Robert W. Baird upped their target price on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. Barclays raised their price target on shares of Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a report on Thursday, April 10th. Finally, Piper Sandler upped their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $27.14.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.